These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Combined insulin and sulfonylurea treatment in diabetes mellitus]. Ravina A; Minuhin O Harefuah; 1986 Jan; 110(1):11-4. PubMed ID: 3514394 [No Abstract] [Full Text] [Related]
3. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials. Johnson JL; Wolf SL; Kabadi UM Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835 [TBL] [Abstract][Full Text] [Related]
4. Glycaemic control in type 2 diabetes. Campbell A Clin Evid; 2005 Dec; (14):474-90. PubMed ID: 16620416 [No Abstract] [Full Text] [Related]
5. Counterpoint: A Diabetes Outcome Progression Trial (ADOPT): good for sulfonylureas? Al-Ozairi E; Sibal L; Home P Diabetes Care; 2007 Jun; 30(6):1677-80. PubMed ID: 17351288 [No Abstract] [Full Text] [Related]
6. Follow-up of intensive glucose control in type 2 diabetes. Mühlhauser I N Engl J Med; 2009 Jan; 360(4):417; author reply 418. PubMed ID: 19172674 [No Abstract] [Full Text] [Related]
7. Effects of alpha-glucosidase inhibitor (acarbose) combined with sulfonylurea or sulfonylurea and metformin in treatment of non-insulin-dependent diabetes mellitus. Vannasaeng S; Ploybutr S; Nitiyanant W; Peerapatdit T; Vichayanrat A J Med Assoc Thai; 1995 Nov; 78(11):578-85. PubMed ID: 8576667 [TBL] [Abstract][Full Text] [Related]
8. [Limited effect of antidiabetics on type 2 diabetes]. Lindeberg S Lakartidningen; 1998 Dec; 95(49):5605-6. PubMed ID: 9863297 [No Abstract] [Full Text] [Related]
9. [Possibilities and limits of oral diabetes therapy]. Bruneder H Wien Med Wochenschr; 1985 Apr; 135(6-7):147-51. PubMed ID: 3890376 [No Abstract] [Full Text] [Related]
10. [Testing insulin and sulfonylurea sensitivity in type II diabetes mellitus]. Holländer E Orv Hetil; 1984 Dec; 125(51):3103-6. PubMed ID: 6392996 [No Abstract] [Full Text] [Related]
12. Pioglitazone with sulfonylurea: glycemic and lipid effects in Taiwanese type 2 diabetic patients. Tseng CH; Huang TS Diabetes Res Clin Pract; 2005 Nov; 70(2):193-4. PubMed ID: 16188579 [No Abstract] [Full Text] [Related]
13. The role of glimepiride in the effective management of Type 2 diabetes. Davis SN J Diabetes Complications; 2004; 18(6):367-76. PubMed ID: 15531188 [TBL] [Abstract][Full Text] [Related]
14. Follow-up of intensive glucose control in type 2 diabetes. Petrie JR N Engl J Med; 2009 Jan; 360(4):416-7; author reply 418. PubMed ID: 19172672 [No Abstract] [Full Text] [Related]
15. Moderate weight loss and sulfonylurea treatment of non-insulin-dependent diabetes mellitus. Combined effects. Liu GC; Coulston AM; Lardinois CK; Hollenbeck CB; Moore JG; Reaven GM Arch Intern Med; 1985 Apr; 145(4):665-9. PubMed ID: 3885889 [TBL] [Abstract][Full Text] [Related]
16. [40 years of using sulfonylurea derivatives for treatment of diabetes]. Sieradzki J Przegl Lek; 1996; 53(9):641-6. PubMed ID: 8992529 [TBL] [Abstract][Full Text] [Related]
17. Non-insulin-dependent diabetes: 10-year outcome in relation to initial response to diet and subsequent sulfonylurea therapy. Sönksen PH; Lowy C; Perkins JR; Lim HS Diabetes Care; 1984; 7 Suppl 1():59-66. PubMed ID: 6376030 [TBL] [Abstract][Full Text] [Related]
18. Recent advances in the treatment of type II diabetes mellitus. Baliga BS; Fonseca VA Am Fam Physician; 1997 Feb; 55(3):817-24. PubMed ID: 9048504 [TBL] [Abstract][Full Text] [Related]
19. Combined chlorpropamide-insulin in the treatment of non-insulin-dependent diabetes mellitus with secondary failure of sulfonylurea therapy. Jiraratsatit J; Keoplung M; Chumsilp L; Chomchoengpatya P; Matayabun S J Med Assoc Thai; 1986 Dec; 69(12):627-34. PubMed ID: 3553408 [No Abstract] [Full Text] [Related]